Gastrointestinal tract involvement in systemic sclerosis: The roles of diet and the microbiomeOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the relationship between gastrointestinal (GI) microbial composition and GI symptoms in patients with systemic sclerosis (SSc). It also compared GI symptoms and microbial composition between SSc patients following a low FODMAP diet versus those not following a low FODMAP diet. Stool specimens underwent bacterial 16S rRNA gene sequencing, and microbial differences were assessed using alpha diversity (species richness, evenness, phylogenetic diversity) and beta diversity (overall composition). Differential abundance analysis was used to identify specific bacterial genera linked to the SSc-GI phenotype and to diet group.
Who was studied?
The study included 66 adult patients with systemic sclerosis who were consecutively recruited and provided stool samples. Patients also completed the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument (GIT 2.0) to assess GI symptoms and the Diet History Questionnaire (DHQ) II to assess dietary intake. Based on their reported intake, patients were classified as adhering to a low or non-low FODMAP diet.
What were the most important findings?
The abstract provided does not include the specific results, so the detailed findings on microbial diversity, differential genera, or symptom associations cannot be reported here. The study design indicates that both alpha diversity and beta diversity metrics were used to compare gut microbial composition across SSc-GI phenotypes and across diet groups. Differential abundance analysis was intended to pinpoint particular bacterial genera associated with GI symptoms and with FODMAP diet status in this SSc cohort.
What are the greatest implications of this study?
By pairing validated GI symptom instruments with dietary history and 16S rRNA sequencing, this approach helps disentangle whether GI microbial alterations in systemic sclerosis are driven by disease-related changes, dietary patterns, or both. Clarifying this distinction could inform whether dietary interventions such as a low FODMAP diet meaningfully influence gut microbial composition and symptom burden in SSc patients. This kind of design lays groundwork for future studies testing whether dietary modification can be used as a targeted strategy to manage SSc-associated GI symptoms.